Home Reimbursed medicines Mirtazapin

Mirtazapin — maximum prices and reimbursement

The CANAMED catalogue contains 23 medicines with the active substance Mirtazapin, from 5 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.

23 CANAMED entries
5 Manufacturers
18.88–76.77 Maximum price (RON)
6 With a reimbursement percentage
Search live prices → All reimbursed medicines →

In short: for the active substance Mirtazapin there are 23 authorised medicines in the CANAMED catalogue, with maximum retail prices between 18.88 and 76.77 RON, from 5 manufacturers. For 6 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.

Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.

CANAMED catalogue

All medicines with Mirtazapin

Maximum retail price = the legal selling cap. Sorted by price, lowest first.

Brand name Manufacturer Maximum price Reimbursement Prescription
MIRZATEN® 30 mg KRKA, D.D., NOVO MESTO - SLOVENIA 18.88 RON 90% · A
CNAS pays ~16.99 RON; you ~1.89 RON*		 PRF
MIRTAZAPIN ARENA 30 mg ARENA GROUP S.A. - ROMANIA 32.05 RON 90% · A
CNAS pays ~28.84 RON; you ~3.21 RON*		 PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA 32.05 RON 90% · A
CNAS pays ~28.84 RON; you ~3.21 RON*		 PRF
MIRTAZAPIN ARENA 15 mg ARENA GROUP S.A. - ROMANIA 33.37 RON 90% · A
CNAS pays ~14.42 RON; you ~18.95 RON*		 PRF
REMERON SOLTAB 30 mg NV ORGANON - OLANDA 54.05 RON 90% · A
CNAS pays ~28.84 RON; you ~25.21 RON*		 PRF
MIRTAZAPIN ARENA 45 mg ARENA GROUP S.A. - ROMANIA 76.77 RON 90% · A
CNAS pays ~43.27 RON; you ~33.50 RON*		 PRF
MIRZATEN® 30 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
MIRZATEN® 30 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
PHARMATAZ 30 mg ACTAVIS LTD. - MALTA — not reimbursed PRF
REMERON SOLTAB 30 mg NV ORGANON - OLANDA — not reimbursed PRF
REMERON SOLTAB 30 mg NV ORGANON - OLANDA — not reimbursed PRF
REMERON SOLTAB 30 mg NV ORGANON - OLANDA — not reimbursed PRF
REMERON SOLTAB 30 mg NV ORGANON - OLANDA — not reimbursed PRF
ZULIN 30 mg S.C. ANTIBIOTICE S.A. - ROMANIA — not reimbursed PRF
ZULIN 30 mg S.C. ANTIBIOTICE S.A. - ROMANIA — not reimbursed PRF

Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.

Prescription status key:

  • PRF — With a medical prescription kept by the pharmacy (P-RF)

Live pharmacy prices

Products with Mirtazapin in our comparator

Shelf prices collected from the large chains — see on each product page where it is cheapest.

Good to know

How to read the maximum price

The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.

CANAMED catalogue

Other active substances in the catalogue

See also the full list of reimbursed medicines, with an alphabetical index of all active substances.

Frequently asked questions

FAQ · Mirtazapin

  1. Is Mirtazapin reimbursed?
    Yes. For 6 of the catalogue entries with Mirtazapin we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement.
  2. What is the CANAMED maximum price for Mirtazapin?
    The maximum retail prices (the CANAMED legal cap) for medicines with Mirtazapin are between 18.88 and 76.77 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator.
  3. What percentage of Mirtazapin is reimbursed?
    The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription.
  4. How many medicines with Mirtazapin are in the CANAMED catalogue?
    The CANAMED catalogue holds 23 authorised medicines with the active substance Mirtazapin — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.

Before you go

Find the best price for Mirtazapin

Compare prices →